These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 5593197

  • 1. [Results of a field study with a live measles vaccine of own production].
    Hempel HC, Starke G, Grimm J, Hlinak P, Nöbel B.
    Dtsch Gesundheitsw; 1967 Mar 23; 22(12):547-52. PubMed ID: 5593197
    [No Abstract] [Full Text] [Related]

  • 2. [Results of testing the effectiveness of live measles virus vaccine by using measles reference virus M1].
    Winkler D, Starke G, Patzwaldt HG, Plaga B.
    Pharmazie; 1972 Sep 23; 27(9):606-8. PubMed ID: 5086359
    [No Abstract] [Full Text] [Related]

  • 3. [Immunity after measles vaccination].
    Nöbel B.
    Z Gesamte Hyg; 1980 Sep 23; 26(12):885-7. PubMed ID: 7234003
    [No Abstract] [Full Text] [Related]

  • 4. [Revaccination against measles].
    Gerike E, Kirchner W, Pöhle W, Tischer A.
    Z Gesamte Hyg; 1983 Feb 23; 29(2):62-5. PubMed ID: 6858258
    [No Abstract] [Full Text] [Related]

  • 5. [Immunization against measles in the GDR and current results of the program to combat measles].
    Starke G, Gerike E, Hlinak P.
    Z Gesamte Hyg; 1980 Feb 23; 26(12):881-5. PubMed ID: 7234002
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 23; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the combined use of killed and live measles vaccines. 3. Conditions for the "take" of live vaccine.
    Ueda S, Hosai H, Minekawa Y, Okuno Y.
    Biken J; 1966 Jun 23; 9(2):97-101. PubMed ID: 5913579
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and serological evaluation of live measles vaccine in India.
    Phadke MA, Rodrigues JJ, Mehta JM, Ayachit V.
    Indian Pediatr; 1983 Aug 23; 20(8):573-6. PubMed ID: 6662582
    [No Abstract] [Full Text] [Related]

  • 15. Studies on the combined use of killed and live measles vaccines. II. Advantages of the inhalation method.
    Okuno Y, Ueda S, Hosai H, Kitawaki T, Nakamura K, Chiang TP, Okabe S, Onaka M, Toyoshima K.
    Biken J; 1965 Jun 23; 8(2):81-5. PubMed ID: 5837767
    [No Abstract] [Full Text] [Related]

  • 16. [Epidemiologic and clinical results of measles immunization in the district Karl-Marx-city].
    Hajduk F, Hempel HC.
    Dtsch Gesundheitsw; 1968 Dec 27; 23(52):2483-9. PubMed ID: 5715950
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An outbreak of measles in a rural Queensland town in 1997; an opportunity to assess vaccine effectiveness.
    Gidding HF, Hills S, Selvey L, Roberts LA, Johnston S.
    Commun Dis Intell; 1999 Sep 02; 23(9):240-5. PubMed ID: 10554408
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.